Endemic Non-Communicable Diseases
Mammograms: Who in the world are they good for? -- live webcast tomorrow March 8: 2:30P.M. TO 3:30P.M. ET
Controversial new evidence suggests that mammography screening for women in high-income nations may have diminishing value in light of effective modern treatment options. But for women in lower-income nations, mammography screening is not enough of a priority, treatment is poor and women face greater risk.
EXPERT PARTICIPANTS
Flavia Bustreo, Assistant Director-General, Family and Community Health, World Health Organization
Felicia Knaul, Director of the Harvard Global Equity Initiative, Secretariat of the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries
Mette Kalager, Researcher and lead author of The New England Journal of Medicine article offering a new assessment of mammography's effectiveness in reducing death rates. She also is a surgeon at Oslo University Hospital and is a visiting scientist at HSPH.
Julie Gralow, Professor and Director, Breast Medical Oncology, University of Washington / Seattle Cancer Care Alliance, and Associate Member, Fred Hutchinson Cancer Research Institute
MODERATOR
Abigail Trafford: Author and Former Health Editor, The Washington Post
Attached resource:
-
Mammograms: Who in the world are they good for? -- live webcast tomorrow March 8: 2:30P.M. TO 3:30P.M. ET (external URL) Link leads to: http://www.hsph.harvard.edu/forum/andelot-mammogram.cfm
Summary: Controversial new evidence suggests that mammography screening for women in high-income nations may have diminishing value in light of effective modern treatment options. But for women in lower-income nations, mammography screening is not enough of a priority, treatment is poor and women face greater risk.
EXPERT PARTICIPANTS
Flavia Bustreo, Assistant Director-General, Family and Community Health, World Health Organization
Felicia Knaul, Director of the Harvard Global Equity Initiative, Secretariat of the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries
Mette Kalager, Researcher and lead author of The New England Journal of Medicine article offering a new assessment of mammography's effectiveness in reducing death rates. She also is a surgeon at Oslo University Hospital and is a visiting scientist at HSPH.
Julie Gralow, Professor and Director, Breast Medical Oncology, University of Washington / Seattle Cancer Care Alliance, and Associate Member, Fred Hutchinson Cancer Research Institute
MODERATOR
Abigail Trafford: Author and Former Health Editor, The Washington PostSource: Harvard School of Public Health
Language: English
Keywords: cancer, Conferences & Meetings
Edit Comment Text